Andere Sprachen Hangzhou Tigermed Consulting Co., Ltd OTC Markets

Aktien

HNGZY

US41044T1088

HNGZY

Verzögert OTC Markets Andere Börsenplätze 17:43:36 19.12.2023			% 5 Tage	% 1. Jan.
4,2 ^USD	-4,55 %		-.--%	-.--%

25.04.	Hangzhou Tigermed Consulting: Gewinnrückgang von 59% in Q1	MT
25.04.	Hangzhou Tigermed Consulting Co., Ltd berichtet über die Ergebnisse für das erste Quartal bis zum 30. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hangzhou Tigermed Consulting’s Profit Down 59% in Q1	25.04.
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024	25.04.
Borse Cina : chiudono miste, male Shanghai -0,7%, bene Hong Kong +1,92%	23.04.
Tigermed Consulting's Profit, Revenue Climb in 2023	29.03.
Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024	28.03.
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes	21.03.
China Healthcare Stocks Rally on Hopes for Government Support	14.03.
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares	14.03.
Hangzhou Tigermed Consulting Plans Up to 1 Billion Yuan Share Repurchase; Shares Jump 4%	07.02.
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.	06.02.
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.	06.02.
Hangzhou Tigermed Consulting's Profit Up 19% in Q3	27.10.23
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Tigermed Reports 2023 Interim Results	28.08.23
Tigermed Consulting's Profit Jumps 16.5% in H1	28.08.23
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	25.08.23
Tigermed Officially Opens International Headquarters in Hong Kong	17.08.23
Bioclub announced that it has received funding from Hangzhou Tigermed Consulting Co., Ltd	07.08.23
Hangzhou Tigermed Consulting Co., Ltd. Announces Final Profit Distribution Plan Implementation (A Shares) for 2022, Payable on 07 July 2023	04.07.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hangzhou Tigermed Consulting Co., Ltd OTC Markets

Aktien

HNGZY

US41044T1088

HNGZY

Andere Sprachen

Filter